Eledon Pharmaceuticals (ELDN) Cash from Operations Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -31.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.59% |
| Dec 31, 2025 | -14.12% |
| Sep 30, 2025 | -46.86% |
| Jun 30, 2025 | -41.77% |
| Mar 31, 2025 | -25.34% |
| Dec 31, 2024 | -27.28% |
| Sep 30, 2024 | -18.39% |
| Jun 30, 2024 | -1.45% |
| Mar 31, 2024 | -19.16% |
| Dec 31, 2023 | 1.08% |
| Sep 30, 2023 | -179.51% |
| Jun 30, 2023 | -39.61% |
| Mar 31, 2023 | -65.30% |
| Dec 31, 2022 | -67.34% |
| Sep 30, 2022 | -16.53% |
| Jun 30, 2022 | -8.10% |
| Mar 31, 2022 | -26.56% |
| Dec 31, 2021 | -40.04% |
| Sep 30, 2021 | -34.20% |
| Jun 30, 2021 | -30.71% |
| Mar 31, 2021 | -31.52% |
| Dec 31, 2020 | -53.44% |
| Sep 30, 2020 | 45.24% |
| Jun 30, 2020 | 27.81% |
| Mar 31, 2020 | -35.56% |
| Dec 31, 2019 | -16.42% |
| Sep 30, 2019 | -25.00% |
| Jun 30, 2019 | -38.37% |
| Mar 31, 2019 | 25.53% |
| Dec 31, 2018 | 27.71% |
| Sep 30, 2018 | 34.09% |
| Jun 30, 2018 | 32.84% |
| Mar 31, 2018 | 41.08% |
| Dec 31, 2017 | 26.06% |
| Sep 30, 2017 | 8.52% |
| Jun 30, 2017 | -14.00% |
| Mar 31, 2017 | 43.05% |
| Dec 31, 2016 | 42.72% |